ArticlePDF Available

Cyclooxygenase-2 (COX-2) polymorphism rs689466 may contribute to the increased susceptibility to post-traumatic osteomyelitis in Chinese population

Authors:

Abstract and Figures

Background: Cyclooxygenase-2 (COX-2) enzyme is one of the major mediators during inflammation reactions, and COX-2 gene polymorphisms of rs20417 and rs689466 have been reported to be associated with several inflammatory diseases. However, potential links between the two polymorphisms and risk of developing post-traumatic osteomyelitis remain unclear. The present study aimed to investigate associations between the rs20417 and rs689466 polymorphisms and susceptibility to post-traumatic osteomyelitis in Chinese population. Methods: A total of 189 patients with definite diagnosis of post-traumatic osteomyelitis and 220 healthy controls were genotyped for rs20417 and rs689466 using the SNaPshot genotyping method. Chi-square test was used to compare differences of genotype distributions as well as outcomes of five different genetic models between the two groups. Results: Significant association was found between rs689466 and post-traumatic osteomyelitis by recessive model (GG vs AA + AG) (OR = 1.74, 95% CI 1.098 – 2.755, P = 0.018). Although no statistical differences were identified of rs689466 between the two groups by allele model (P = 0.098) or homozygous model (P = 0.084), outcomes revealed a tendency that allele G may be a risk factor and people of GG genotype may be in a higher risk to develop post-traumatic osteomyelitis in Chinese population. However, no significant link was found between rs20417 and susceptibility to post-traumatic osteomyelitis in this Chinese cohort. Conclusions: To our knowledge, we reported for the first time that COX-2 gene polymorphism rs689466 may contribute to the increased susceptibility to post-traumatic osteomyelitis in Chinese population.
Content may be subject to copyright.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=infd20
Download by: [Southern Medical University] Date: 21 August 2017, At: 15:42
Infectious Diseases
ISSN: 2374-4235 (Print) 2374-4243 (Online) Journal homepage: http://www.tandfonline.com/loi/infd20
Cyclooxygenase-2 (COX-2) polymorphism rs689466
may contribute to the increased susceptibility
to post-traumatic osteomyelitis in Chinese
population
Lei Wang, Nan Jiang, Qing-rong Lin, Cheng-he Qin, Yan-jun Hu & Bin Yu
To cite this article: Lei Wang, Nan Jiang, Qing-rong Lin, Cheng-he Qin, Yan-jun Hu & Bin Yu
(2017) Cyclooxygenase-2 (COX-2) polymorphism rs689466 may contribute to the increased
susceptibility to post-traumatic osteomyelitis in Chinese population, Infectious Diseases, 49:11-12,
817-823, DOI: 10.1080/23744235.2017.1347816
To link to this article: http://dx.doi.org/10.1080/23744235.2017.1347816
Published online: 06 Jul 2017.
Submit your article to this journal
Article views: 17
View related articles
View Crossmark data
INFECTIOUS DISEASES,
2017; VOL. 49,
NO. 11-12, 817823
https://doi.org/10.1080/23744235.2017.1347816
ORIGINAL ARTICLE
Cyclooxygenase-2 (COX-2) polymorphism rs689466
may contribute to the increased susceptibility to
post-traumatic osteomyelitis in Chinese population
Lei Wang
a
, Nan Jiang
a,b
, Qing-rong Lin
a
, Cheng-he Qin
a
, Yan-jun Hu
a
and Bin Yu
a,b
a
Department of Orthopaedics and Traumatology, Nanfang Hospital, Southern Medical University, Guangzhou, PR China;
b
Guangdong Provincial Key Laboratory of Bone and Cartilage Regenerative Medicine, Nanfang Hospital, Southern Medical
University, Guangzhou, PR China
ABSTRACT
Background: Cyclooxygenase-2 (COX-2) enzyme is one of the major mediators during inflammation reactions, and COX-2
gene polymorphisms of rs20417 and rs689466 have been reported to be associated with several inflammatory diseases.
However, potential links between the two polymorphisms and risk of developing post-traumatic osteomyelitis remain
unclear. The present study aimed to investigate associations between the rs20417 and rs689466 polymorphisms and sus-
ceptibility to post-traumatic osteomyelitis in Chinese population.
Methods: A total of 189 patients with definite diagnosis of post-traumatic osteomyelitis and 220 healthy controls were gen-
otyped for rs20417 and rs689466 using the SNaPshot genotyping method. Chi-square test was used to compare differences
of genotype distributions as well as outcomes of five different genetic models between the two groups.
Results: Significant association was found between rs689466 and post-traumatic osteomyelitis by recessive model (GG vs.
AA þAG) (OR ¼1.74, 95% CI: 1.0982.755, p¼.018). Although no statistical differences were identified of rs689466 between
the two groups by allele model (p¼.098) or homozygous model (p¼.084), outcomes revealed a tendency that allele G
may be a risk factor and people of GG genotype may be in a higher risk to develop post-traumatic osteomyelitis in
Chinese population. However, no significant link was found between rs20417 and susceptibility to post-traumatic osteomye-
litis in this Chinese cohort.
Conclusions: To our knowledge, we reported for the first time that COX-2 gene polymorphism rs689466 may contribute to
the increased susceptibility to post-traumatic osteomyelitis in Chinese population.
KEYWORDS
Post-traumatic osteomyelitis
single nucleotide polymorphism
COX-2 gene
rs20417
rs689466
case-control study
ARTICLE HISTORY
Received 14 July 2016
Revised 12 December 2016
Accepted 13 June 2017
CONTACT
B. Yu
nanfanghot@126.com;
Y.-j. Hu
huyanjun1212@163.com
Department of Orthopaedics and
Traumatology, Nanfang Hospital, No. 1838,
Guangzhou Ave. North, Baiyun District,
Guangzhou 510515, PR China
These authors contributed equally to this work.
ß2017 Society for Scandinavian Journal of Infectious Diseases
Downloaded by [Southern Medical University] at 15:42 21 August 2017
Introduction
Cyclooxygenase (COX), also known as prostaglandin syn-
thetase (PTGS), acts as the key enzyme in the conversion
of free arachidonic acid into prostaglandins. COX partici-
pates in the regulation of inflammatory reaction proc-
esses through its products including prostaglandin E2
(PGE2), PGI2 and PGD2 [1]. COX is encoded by at least
two COX genes (COX-1 and COX-2). As one type of COX
enzymes, COX-2 plays an important role in the regula-
tion of prostanoids products, which associates with
lesion, inflammation and proliferation [2]. Human COX-2,
encoded by COX-2 gene, is located on chromosome
1q25.2-25.3, contains 10 exons, and is approximately
8.3 kb with a 4.5 kb transcript [3]. The 50flanking region
of this gene mainly participants in the regulation of
gene transcription, which contains a canonical TATA box
and several putative transcription-factor binding sites,
such as nuclear factor-jB, nuclear factor-IL-6 and a trans-
forming growth factor-bresponse element, demonstrat-
ing that a complex array of factors is involved in COX-2
gene regulation [4]. Among potential factors that affect
transcription of COX-2 gene, single nucleotide poly-
morphism (SNP) in the gene promoter is an important
aspect. The most frequently investigated functional poly-
morphisms of COX-2 gene, 765G >C (rs20417) and
1195G >A (rs689466), have been reported to be corre-
lated with several different inflammatory disorders, such
as chronic periodontitis [5,6], inflammatory bowel dis-
eases [7,8] and subclinical atherosclerosis [9]. This is
probably because these gene polymorphisms may alter
the function of COX-2 enzyme by regulation of COX-2
expression and thus, affect the synthesis of prostaglan-
dins [4,10], which involve in the pathogenesis of inflam-
matory diseases.
As a frequent type of inflammatory diseases in clinical
orthopaedics, chronic osteomyelitis (COM) is character-
ized by progressive inflammatory destruction with
new bone formation, simultaneously [11]. With respect
to disease incidence, a recent study [12] reported that
incidence of osteomyelitis in America population
between 2000 and 2009 was over twice than that
between 1969 and 1979 (24.4/100,000 vs. 11.4/100,000
person-year). Although such data were still lacking in
Chinese population, incidence of COM is in China may
be not lower than that in America, which is probably
due to the larger number of population, growing num-
ber of traffic [13] and industrial accidents in China.
Previous studies have demonstrated that healthy bone is
highly resistant to infection, which usually occurs
following large amount of inocula, severe injury and the
presence of foreign bodies. A recent study [14] indicated
that the risk of osteomyelitis following trauma and
orthopaedic surgery varied, ranging from 1% to 55%,
especially for patients with type III open fractures
(955%) by GustiloAnderson classification. The huge
digital variance implies, in addition to external factors,
host factors may also participate in the pathogenesis
of COM.
Previous studies have investigated potential roles of
host factors in the pathogenesis of COM from perspec-
tive of SNP. Osman et al. [15] reported that A allele of
rs1800871 may be risk factor for haematogenous osteo-
myelitis in Saudi Arabia. Valle-Garay et al. [16] found that
tissue plasminogen activator Alu (I/D) polymorphism may
contribute to the elevated susceptibility to bacterial
osteomyelitis in Spanish. In addition, Tsezou et al. [17]
indicated polymorphisms of interleukin-1a(IL-1a)889-
C/T, IL-4 1098-G/T and 590-C/T and IL-6 174-G/C
may increase the risk of developing COM in Greek popu-
lation. Outcomes of the above studies suggest that, as
an important aspect of host factors, SNP may involve in
the pathogenesis of COM.
Considering the above-mentioned positive relation-
ships between COX-2 gene polymorphisms and risks of
developing different inflammatory disorders as well as
the growing evidence of links between SNP and suscep-
tibility to COM, we hypothesized that COX-2 gene poly-
morphisms may be one of the pathogenetic factors of
COM. Therefore, the present study aimed to investigated
COX-2 gene polymorphisms (rs20417 and rs689466) and
susceptibility to post-traumatic osteomyelitis, one of the
most frequent COM type in Chinese population.
Materials and methods
Study design, setting, definition and population
The present study was designed as a case-control ana-
lysis. Patient group were those diagnosed with post-trau-
matic osteomyelitis in Nanfang Hospital, Guangzhou,
South China, between August 2013 and October 2015.
Post-traumatic osteomyelitis was defined as a persistent
or a long-term bone infection (at least for 10 weeks
[18,19]) following open fracture or internal fixations for
closed fracture. Diagnosis of the disease was built on
intraoperative pathological tests, or cultures from at least
two infection sites with the same organism or a definite
sinus tract connecting directly the bone. Healthy controls
were individuals without any abnormalities after thor-
ough examination in the physical examination centre of
818 L. WANG ET AL.
Downloaded by [Southern Medical University] at 15:42 21 August 2017
our hospital. All the included participants signed the
informed consent and the current study was in accord-
ance with the tenets of Helsinki declaration. The proto-
col of the study was approved by medical ethics
committee of Nanfang Hospital, Southern Medical
University.
SNP genotyping
Ethylene diamine tetraacetic acid (EDTA) peripheral
blood samples (2 ml for each) were collected. The two
tag SNPs of the COX-2 gene (rs20417 and rs689466)
were genotyped using the Multiplex SNaPshot system
(Applied Biosystems, Foster City, CA). The detailed proce-
dures of the genotyping method were described previ-
ously [20]. The forward (F) and reverse (R) primers used
for polymerase chain reaction (PCR) and extension reac-
tions were: for rs20417: F: 50-GCCTTAAGGCATACG
TTTTGG-30,R:5
0-TACTGTTCTCCGTACCT TCAC-30, exten-
sion primer: 50-TTTTTTTTTTCCTTGTTTCTTGGAAAGAGAGG-
30. For rs689466: F: 50-TAGTATCTCACCCTCACATGC-30,R:
50-CCAAGATTATGAGTTGTG ACC-30, extension primer: 50-
CAAAAGCAAAGATGAAATTCCA-30.
Primary and secondary outcomes
Primary outcomes were comparisons for frequencies of
rs20417 and rs689466 between the two groups, includ-
ing genotype distribution, mutant allele frequency and
four genetic models (dominant, recessive, homozygous
and heterozygous models). Secondary outcomes were
clinical characteristics of post-traumatic osteomyelitis,
comparisons of clinical features and preoperative serum
levels of inflammatory cytokines [white blood cell count
(WBC), C-reactive protein (CRP), procalcitonin (PCT), inter-
leukin-6 (IL-6), tumour necrosis factor-a(TNF-a), serum
amyloid A (SAA)] among different genotypes of the two
COX-2 gene polymorphisms in the patient group.
Statistical analysis
Statistical analysis was conducted using the SPSS 17.0
software (SPSS Inc, Chicago, IL). Data distribution was
assessed for normality using the KolmogorovSmirnov
test. Continuous variables were revealed as the mean-
± standard deviation or median with interquartile range
(IQR) depending on data distribution. Studentst-test or
MannWhitney Utest was applied for normally or abnor-
mally distributed continuous variables, respectively.
Genotype frequency distributions for healthy controls
were tested for the confirmation to HardyWeinberg
equilibrium (HWE) using the v
2
test. The v
2
or Fisher
exact test was used to compare the frequencies of geno-
types between the two groups, with corresponding odds
ratios (ORs) and 95% confidence intervals (CIs). A pvalue
of .05 was defined as statistical significance.
Results
Baseline data between patients and healthy controls
A total of 189 patients (156 males and 33 females) with
extremity post-traumatic COM and 220 healthy controls
(167 males and 53 females) were included in the present
study finally. The gender ratio between the two groups
showed statistical difference (4.73 vs. 3.15, v
2
¼2.692,
p¼.101). However, no significant difference was also
found regarding the median age between the two
groups (patient group: 42 years, IQR: 2850, vs. control
group: 41.5 years, IQR: 3749, Z¼1.820, p¼.069).
Characteristics of patients diagnosed with post-
traumatic osteomyelitis
Clinical characteristics of post-traumatic osteomyelitis in
this Chinese cohort are shown in Table 1. The top three
injury types accounting for post-traumatic osteomyelitis
were traffic accident (46.01%), blunt injury (30.67%) and
falling injury (12.27%). Post-traumatic osteomyelitis was
mainly caused by open fractures (67.04%). The most fre-
quent single infection site was tibia (50.58%) and posi-
tive rate of pathogen culture was only 61.64%, with
Staphylococcus aureus (31.88%) as the most common
pathogen (Table 1).
Table 1. Clinical characteristics of post-traumatic osteomyelitis in
this Chinese cohort.
Clinical characteristics Outcomes
Top three injury type
Traffic accidents E/T (%) 75/163 (46.01)
Blunt injury E/T (%) 50/163 (30.67)
Falling injury E/T (%) 20/163 (12.27)
Open fractures E/T (%) 120/179 (67.04)
Infection side distribution left/right/bilateral 101/87/1
Infection site number single/multiple 172/17
Top three single infection site E/T (%)
Tibia 87/172 (50.58)
Femur 51/172 (29.65)
Calcaneus 12/172 (6.98)
Positive rate of pathogen culture E/T (%) 90/146 (61.64)
Pathogen for infection monomicrobial/polymicrobial 69/21
Pathogen for monomicrobial infection E/T (%)
Staphylococcus aureus 22/69 (31.88)
Pseudomonas aeruginosa 19/69 (27.54)
Staphylococcus epidermidis 5/69 (7.25)
Acinetobacter baumannii 4/69 (5.80)
Escherichia coli 4/69 (5.80)
Others 15/69 (21.73)
E/T, events/total (available data).
INFECTIOUS DISEASES 819
Downloaded by [Southern Medical University] at 15:42 21 August 2017
Frequency of the two COX-2 gene polymorphisms in
patients and healthy controls
All genotyped SNPs were in HWE for healthy controls
(For rs20417, p
(HWE)
¼.551, for rs689466, p
(HWE)
¼.487).
As shown in Table 2, significant association was found
between rs689466 and post-traumatic osteomyelitis by
recessive model (GG vs. AA þAG) (OR ¼1.74, 95% CI:
1.0982.755, p¼.018). Although no statistical differences
were identified of rs689466 between the two groups by
allele model (G vs. A, OR ¼1.262, 95% CI: 0.9581.662,
p¼.098) or homozygous model (GG vs. AA, OR ¼1.612,
95% CI: 0.9362.775, p¼.084), outcomes revealed a ten-
dency that allele G may be a risk factor and people of
GG genotype may be in a higher risk to develop post-
traumatic osteomyelitis in Chinese population. However,
no significant association was observed between COX-2
rs20417 polymorphism and the susceptibility to post-
traumatic osteomyelitis (Table 2).
Comparisons of clinical features and preoperative
serum levels of different inflammatory cytokines
among different genotypes of the COX-2 gene
polymorphisms in patient group
As revealed in Table 3, significant difference was found
regarding serum IL-6 levels among three different geno-
types of rs20417 (p¼.017). However, considering only
one patient data was available for analysis in the CC
group, we removed this group and performed further
comparisons between the GG and CG genotype groups.
Outcomes showed significantly higher serum levels of
CRP (p¼.017) and IL-6 (p¼.006) in the GG group than
those in the CG group. With respect to outcomes among
genotype groups of rs689466, in addition to the statis-
tical difference of sex ratio among the three genotype
groups (p¼.014), no significant differences were identi-
fied in another outcomes.
Discussion
Outcomes of the current study suggest that COX-2 gene
polymorphism rs689466 may contribute to the increased
susceptibility to post-traumatic osteomyelitis in Chinese
population. People with GG genotype of rs689466 poly-
morphism may be a higher risk group to develop post-
traumatic osteomyelitis.
COM is defined as pathogens or auto-inflammatory
diseases associated, a persistent or a long term bone
infections. Nowadays, COM still represents great chal-
lenges to clinicians, not only for its complex treatment
Table 2. Frequency of COX-2 gene polymorphisms (rs20417 and rs689466) in patients with post-traumatic osteomyelitis and healthy controls.
SNP site Genotype distribution no. (%) Dominant model Recessive model Allele model Homozygous model Heterozygous model
Patients Controls pValue pValue OR (95%CI) pValue OR (95%CI) pValue OR (95% CI) pValue OR (95% CI) pValue OR (95% CI)
rs20417 GG þCG vs. CC GG vs. CC þCG G vs. C GG vs. CC CG vs. CC
CC 1 (0.5) 0 (0.0) .113 p¼.462 p¼.095 p¼.076 p¼.450 p¼1.000
CG 23 (12.2) 17 (7.7) OR ¼0.995 OR ¼0.576 OR ¼0.567 OR ¼0.994 OR ¼0.958
GG 165 (87.3) 203 (92.3) 95% CI: 0.9841.005 95% CI: 0.2991.108 95% CI: 0.3021.068 95% CI:0.9821.006 95% CI: 0.8821.042
rs689466 GG þAG vs. AA GG vs. AA þAG G vs. A GG vs. AA AG vs. AA
AA 52 (27.5) 64 (29.1) .053 p¼.724 p¼.018 p¼.098 p¼.084 p¼.606
AG 82 (43.4) 114 (51.8) OR ¼1.081 OR ¼1.740 OR ¼1.262 OR ¼1.612 OR ¼0.885
GG 55 (29.1) 42 (19.1) 95% CI: 0.7021.665 95% CI: 1.0982.755 95%CI: 0.9581.662 95% CI: 0.9362.775 95% CI: 0.5571.407
Bold Value signifies p0.05.
SNP, single-nucleotide polymorphism; OR, odds ratio; CI, confidence interval.
820 L. WANG ET AL.
Downloaded by [Southern Medical University] at 15:42 21 August 2017
and a higher risk of recurrence [18], but also for the sig-
nificantly increased economic cost [21] and burden, both
personally and socially. In addition, patients with COM
suffer from a higher risk of disabilities, both physically
and psychologically [22]. Moreover, outcomes of several
recent studies revealed that patients with COM may
have elevated susceptibility to other accompanying dis-
eases, such as rheumatoid arthritis [23], ischaemic stroke
[24] and diabetes mellitus [25]. COM used to be seque-
lae of acute haematogenous osteomyelitis, but has
recently increasing from post-traumatic osteomyelitis
(open fractures and closed fracture for internal fixation)
and diabetic foot osteomyelitis. The average incidence
of post-traumatic osteomyelitis is approximately 5% [26],
which is affected by both external/environmental and
internal/host factors. Currently, external factors have
been widely reported [14], however, explorations on
host factors remain quite few. In recent years, several
studies tried to investigate potential roles of host factors
for osteomyelitis from perspective of SNP, which pro-
vided new insight into the pathogenesis of COM.
As mentioned previously, COX-2 associates with
inflammation through the regulation of prostanoids
products, serum level of which may be affected by COX-
2gene polymorphisms. Currently, rs20417 and rs689466
are the most frequently reported two polymorphisms
sites of COX-2 gene. In addition to the inflammatory dis-
eases, previous studies also reported that the two gene
polymorphisms may be associated with the risk of devel-
oping another diseases, such as colorectal cancer [27],
breast cancer [28] and acute myeloid leukemia (AML)
[29]. In the present study, we found rs689466 may be
linked to the increased susceptibility to post-traumatic
osteomyelitis. In addition, outcomes of recessive model
imply that people with GG genotype of rs689466 may
be a group with a higher risk for the susceptibility to
post-traumatic osteomyelitis in Chinese population.
In order to explain potential roles of the COX-2 gene
polymorphisms in the pathogenesis of post-traumatic
osteomyelitis, we compared clinical features as well as
preoperative serum levels of six different cytokines
among different genotypes of rs20417 and rs689466.
However, in addition to the statistical differences of IL-6
levels among genotypes of rs20417 and sex ratios
among genotypes of rs689466, no significant differences
were identified in another aspect among the genotype
groups of the two sites. This may be caused by the fact
that post-traumatic osteomyelitis is injury associated dis-
ease, serum cytokines levels are affected by many exter-
nal factors apart from genetic variations, such as injury
Table 3. Comparisons of clinical characteristics among different genotypes of the COX-2 gene polymorphisms in patients with post-traumatic osteomyelitis.
Items rs20417 rs689466
GG CG CC pValue GG AG AA pValue
Age 38.8 ± 15.17 34.39 ± 14.93 26.00 .309
a
39.6 ± 13.74 35.5 ± 14.82 40.96 ± 16.62 .090
Sex ratio (M/F) 136/29 20/3 0/1 .164 43/12 75/7 38/14 .014
Positive rate of culture (%) (E/T) 62.31 (81/130) 56.25 (9/16) NA .638
a
60.46 (26/43) 64.41 (38/59) 59.09 (26/44) .845
Polymicrobial infection (%) (E/T) 24.69 (20/81) 11.11 (1/9) NA .618
a
11.54 (3/26) 31.58 (12/38) 23.08 (6/26) .177
WBC (10
9
/l) Median 7.16 6.58 6.80 .880 6.59 7.34 6.98 .266
(IQR) (5.82, 8.53) (5.73, 8.57) (6.80, 6.80) (5.35, 81.4) (6.04, 8.56) (5.79, 8.56)
CRP (mg/l) Median 6.25 2.8 8.17 .054 5.75 4.82 5.89 .424
(IQR) (2.52, 18.63) (1.69, 9.1) (8.17, 8.17) (1.84, 15.83) (1.67, 14.01) (3.57, 17.72)
PCT (ng/ml) Median 0.034 0.036 0.020 .373 0.031 0.036 0.033 .994
(IQR) (0.023, 0.051) (0.022, 0.071) (0.02, 0.02) (0.024, 0.047) (0.024, 0.048) (0.022, 0.062)
IL-6 (pg/ml) Median 17.92 7.66 46.93 .017 11.37 17.74 18.39 .373
(IQR) (8.17, 80.93) (3.07, 29.72) (46.93, 46.93) (5.08, 81.02) (8.62, 73.50) (6.97, 48.56)
TNF-a(pg/ml) Median 9.31 8.63 11.30 .443 9.67 9.14 9.42 .500
(IQR) (7.57, 12.00) (6.60, 11.77) (11.3, 11.3) (7.60, 11.15) (7.03, 11.75) (8.01, 13.80)
SAA (mg/l) Median 9.40 5.50 3.30 .504 17.60 5.95 11.90 .378
(IQR) (3.75, 29.05) (1.75, 84.05) (3.30, 3.30) (5.02, 46.60) (2.42, 19.45) (3.32, 21.27)
Bold Values signify p0.05.
IQR, interquartile range; M/F, male/female; E/T, events/total; WBC, white blood cell count; CRP, C-reactive protein; PCT, procalcitonin; IL-6, interleukin-6; TNF-a, tumour necrosis factor-a; SAA, serum amyloid A.
a
Comparisons were performed between patients with the GG and CG genotype groups of rs20417.
INFECTIOUS DISEASES 821
Downloaded by [Southern Medical University] at 15:42 21 August 2017
type and degree, previous intervention, disease course.
Therefore, in order to eliminate influences of external
factors, the optimal patients to investigate effects of
host genetic variations on COM are those with haema-
togenous OM. However, these patients represent just
approximate 15% of all COM patients [30] and conse-
quently, large sample series of haematogenous OM
patients are quite difficult to collect.
The present study had several limitations. Firstly,
although sample size of the present study is larger than
most of the published studies on COM SNPs, it is still far
from enough to confirm the conclusions with reliability.
In addition, lopsided gender distribution between
patients and healthy controls may also affect outcomes.
Therefore, more studies with a larger sample size are
warranted. Secondly, conclusions of this study were just
built on case-control comparisons, future functional
explorations should be performed to testify that carriers
of the COX-2 gene rs689466 SNP GG genotype are more
prone to post-traumatic osteomyelitis. Furthermore,
potential mechanisms underlying these outcomes should
be conducted. Thirdly, due to the fact that post-trau-
matic osteomyelitis is a more complex inflammatory dis-
ease, more SNPs sites should be included for analysis to
better evaluate roles of genetic variations in the patho-
genesis of such injury associated infection.
In conclusion, we reported for the first time that COX-
2 gene polymorphism rs689466 may contribute to the
elevated susceptibility to post-traumatic osteomyelitis in
Chinese population. Moreover, population with GG
genotype of this site may be a group with a higher risk
to develop such disorder.
Acknowledgements
The authors thank Prof. Allen P. Liang for his contribution to
revise this paper.
Disclosure statement
The authors declare that they have no conflict of interests.
Funding
This study was supported by National Natural Science Foundation
of China (Grant No. 81572165), Guangdong Provincial Science and
Technology Department Plan Projects (Grant No.
2016B090913004), Guangzhou Science and Technology Program
key projects Plan Projects (Grant No. 201508020035) and
Presidential Foundation of Nanfang Hospital (Grant No.2014C014).
References
[1] Warner TD, Mitchell JA. Cyclooxygenases: new forms, new
inhibitors, and lessons from the clinic. FASEB J. 2004;
18:790804.
[2] Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2.
Annu Rev Pharmacol Toxicol. 1998;38:97120.
[3] Tay A, Squire JA, Goldberg H, et al. Assignment of the
human prostaglandin-endoperoxide synthase 2 (PTGS2)
gene to 1q25 by fluorescence in situ hybridization.
Genomics. 1994;23:718719.
[4] Papafili A, Hill MR, Brull DJ, et al. Common promoter variant
in cyclooxygenase-2 represses gene expression: evidence of
role in acute-phase inflammatory response. Arterioscler
Thromb Vasc Biol. 2002;22:16311636.
[5] Prakash G, Umar M, Ajay S, et al. COX-2 gene polymor-
phisms and risk of chronic periodontitis: a case-control
study and meta-analysis. Oral Dis. 2015;21:3845.
[6] Xie CJ, Xiao LM, Fan WH, et al. Common single nucleotide
polymorphisms in cyclooxygenase-2 and risk of severe
chronic periodontitis in a Chinese population. J Clin
Periodontol. 2009;36:198203.
[7] Andersen V, Nimmo E, Krarup HB, et al. Cyclooxygenase-2
(COX-2) polymorphisms and risk of inflammatory bowel dis-
ease in a Scottish and Danish case-control study. Inflamm
Bowel Dis. 2011;17:937946.
[8] de Vries HS, te Morsche RH, van Oijen MG, et al. The func-
tional 765G>C polymorphism of the COX-2 gene may
reduce the risk of developing Crohn's disease. Plos One.
2010;11:e15011.
[9] Rudock ME, Liu Y, Ziegler JT, et al. Association of polymor-
phisms in cyclooxygenase (COX)-2 with coronary and
carotid calcium in the Diabetes Heart Study.
Atherosclerosis. 2009;203:459465.
[10] Wu GL, Cai HY, Cai HB, et al. Influence of the cyclooxyge-
nase-2 Gene 765G/C and 1195G/A polymorphisms on
development of ischemic stroke. J Stroke Cerebrovasc Dis.
2016;25:21262135.
[11] Panteli M, Giannoudis PV. Chronic osteomyelitis: what the
surgeon needs to know. Efort Open Rev. 2016;1:128135.
[12] Kremers HM, Nwojo ME, Ransom JE, et al. Trends in the epi-
demiology of osteomyelitis: a population-based study, 1969
to 2009. J Bone Joint Surg Am. 2015;97:837845.
[13] Zhou J, Li Y, Wang QK, et al. Status of road safety and
injury burden: China. J Orthop Trauma. 2014;28:S41S42.
[14] Hogan A, Heppert VG, Suda AJ. Osteomyelitis. Arch Orthop
Trauma Surg. 2013;133:11831196.
[15] Osman AE, Mubasher M, ElSheikh NE, et al. Investigation of
polymorphisms in anti-inflammatory cytokine genes in
hematogenous osteomyelitis. Genet Mol Res. 2015;14:
1698116986.
[16] Valle-Garay E, Montes AH, Corte JR, et al. tPA Alu (I/D) poly-
morphism associates with bacterial osteomyelitis. J Infect
Dis. 2013;208:218223.
[17] Tsezou A, Poultsides L, Kostopoulou F, et al. Influence of
interleukin 1alpha (IL-1alpha), IL-4, and IL-6 polymorphisms
on genetic susceptibility to chronic osteomyelitis. Clin
Vaccine Immunol. 2008;15:18881890.
822 L. WANG ET AL.
Downloaded by [Southern Medical University] at 15:42 21 August 2017
[18] Metsemakers WJ, Kuehl R, Moriarty TF, et al. Infection after
fracture fixation: current surgical and microbiological con-
cepts. Injury. 2016. doi: 10.1016/j.injury.2016.09.019
[19] Zimmerli W. Clinical presentation and treatment of ortho-
paedic implant-associated infection. J Intern Med. 2014;
276:111119.
[20] Jiang N, Zhao XQ, Qin CH, et al. Association of vitamin D
receptor gene TaqI, BsmI, FokI and ApaI polymorphisms
and susceptibility to extremity chronic osteomyelitis in
Chinese population. Injury. 2016;47:16551660.
[21] Thakore RV, Greenberg SE, Shi H, et al. Surgical site infec-
tion in orthopedic trauma: a case-control study evaluating
risk factors and cost. J Clin Orthop Trauma. 2015;6:220226.
[22] Tseng CH, Huang WS, Muo CH, et al. Increased depression
risk among patients with chronic osteomyelitis.
J Psychosom Res. 2014;77:535540.
[23] Ho MW, Tseng CH, Chen JH, et al. Chronic osteomyelitis as
a risk factor for development of rheumatoid arthritis:
a nationwide, population-based, cohort study. Clin
Rheumatol. 2015;9:15211527.
[24] Tseng CH, Chen JH, Muo CH, et al. Increased risk of ischae-
mic stroke amongst patients with chronic osteomyelitis: a
population-based cohort study in Taiwan. Eur J Neurol.
2015;22:633639.
[25] Lin SY, Lin CL, Tseng CH, et al. The association between
chronic osteomyelitis and increased risk of diabetes melli-
tus: a population-based cohort study. Eur J Clin Microbiol
Infect Dis. 2014;33:16471652.
[26] Trampuz A, Zimmerli W. Diagnosis and treatment of infec-
tions associated with fracture-fixation devices. Injury.
2006;37:S59S66.
[27] Li H, Guo Q, Zhou B, et al. Cyclooxygenase-2 gene
polymorphisms and the risk of colorectal
cancer: a population-based study. Oncol Lett. 2015;10:
18631869.
[28] Dai ZJ, Shao YP, Ma XB, et al. Association of the three com-
mon SNPs of cyclooxygenase-2 gene (rs20417, rs689466,
and rs5275) with the susceptibility of breast cancer: an
updated meta-analysis involving 34,590 subjects. Dis
Markers. 2014;2014:484729.
[29] Zheng J, Chen S, Jiang L, et al. Functional genetic variations
of cyclooxygenase-2 and susceptibility to acute myeloid
leukemia in a Chinese population. Eur J Haematol.
2011;87:486493.
[30] Jiang N, Ma YF, Jiang Y, et al. Clinical characteristics and
treatment of extremity chronic osteomyelitis in Southern
China: a retrospective analysis of 394 consecutive patients.
Medicine (Baltimore). 2015;94:e1874.
INFECTIOUS DISEASES 823
Downloaded by [Southern Medical University] at 15:42 21 August 2017
... However, the association between NLRP3 and COM, as well as the underlying mechanisms remain unclear. Previous studies had reported that several single nucleotide polymorphisms (SNPs), such as TaqI (rs731236) and FokI (rs2228570) in the vitamin D receptor (VDR) gene [23], rs689466 in the cyclooxygenase-2 (COX-2) gene [24], the Alu insertion/deletion (rs4646972) in the tissue plasminogen activator (tPA) gene [25], and rs1799750 in the matrix metalloprotease 1 (MMP-1) gene [26], may be associated with the risk of developing COM. In the HaploReg v4.2-Broad Institute (HaploReg v4.2 (broadinstitute.org)), ...
... Studies have shown that genetic variables, with SNP as a key component, may play a role in the etiology of infection. According to several clinical studies, the VDR [23], tPA [25], COX-2 [24], and MMP-1 [26] genes, and the most frequently reported members of the IL family, have been implicated in the associations between SNPs and COM risk across various ethnicities. Previous investigations reported that IL-1 (rs1800587) [36,37], IL-4 (rs2243250, rs2243248) [37], and IL-6 (rs1800795) [37] gene polymorphisms are positively correlated with the development of COM and raise the risk of developing OM. ...
Article
Full-text available
Background Single nucleotide polymorphisms (SNPs) in the nucleotide-binding domain leucine-rich repeat protein-3 (NLRP3) gene are reported to be linked to many inflammatory disorders. However, uncertainty persists over the associations between these SNPs and susceptibilities to chronic osteomyelitis (COM). This study aimed to investigate potential relationships between NLRP3 gene SNPs and the risks of developing COM in a Chinese Han cohort. Methods The four tag SNPs of the NLRP3 gene were genotyped in a total of 428 COM patients and 368 healthy controlsusing the SNapShot technique. The genotype distribution, mutant allele frequency, and the four genetic models (dominant, recessive, homozygous, and heterozygous) of the four SNPs were compared between the two groups. Results A significant association was found between rs10754558 polymorphism and the probability of COM occurence by the heterozygous model (P = 0.037, odds ratio [OR] = 1.541, 95% confidence interval [CI] = 1.025–2.319), indicating that rs10754558 may be associated with a higher risk of developing COM.In addition, possible relationship was found between rs7525979 polymorphism and the risk of COM development by the outcomes of homozygous (P = 0.073, OR = 0.453, 95% CI = 0.187–1.097) and recessive (P = 0.093, OR = 0.478, 95% CI = 0.198–1.151) models, though no statistical differences were obtained. Conclusions Outcomes of the present study showed, for the first time, that rs10754558 polymorphism of the NLRP3 gene may increase the risk of COM development in this Chinese Han population, with genotype CG as a risk factor. Nonetheless, this conclusion requires verification from further studies with a larger sample size.
... Genetic predisposition plays a significant role in the development of PTOM. According to Wang et al., the GG genotype of the cyclooxygenase-2 (COX-2) gene enhances vulnerability to PTOM in the Chinese population [7]. Alves De Souza et al. reported that the 2 of 10 Brazilian population might be more likely to acquire PTOM owing to interleukin (IL) gene polymorphisms rs16944 and rs2234663 [8]. ...
... Genetic predisposition plays a significant role in the development of PTOM. According to Wang et al., the GG genotype of the cyclooxygenase-2 (COX-2) gene enhances vulnerability to PTOM in the Chinese population [7]. Alves De Souza et al. reported that the Brazilian population might be more likely to acquire PTOM owing to interleukin (IL) gene polymorphisms rs16944 and rs2234663 [8]. ...
Article
Full-text available
The purpose of this case–control study was to examine possible links between NLRP3 gene polymorphisms and the risk of developing posttraumatic osteomyelitis (PTOM) in the Chinese population. A total of 306 patients with PTOM and 368 normal controls were genotyped for NLRP3 (rs35829419, rs10754558, rs7525979, rs4612666), ELP2 (rs1785929, rs1789547, rs1785928, rs12185396, rs681757, rs8299, rs2032206, rs559289), STAT3 (rs4796793, rs744166, rs1026916, rs2293152, rs1053004), CASP1 (rs501192, rs580253, rs556205, rs530537), NFKBIA (rs696), NFKB1 (rs4648068), CARD8 (rs204321), and CD14 (rs2569190) using the genotyping technique SNaPshot. The genotype distributions of NLRP3 gene rs10754558 (p = 0.047) and rs7525979 (p = 0.048) significantly differed between the patients and the healthy controls. Additionally, heterozygous models indicated a significant association between NLRP3 rs10754558 and the likelihood of developing PTOM (OR = 1.600, p = 0.039), as did recessive and homozygous models of NLRP3 rs7525979 (OR = 0.248, p = 0.019 and 0.239, p = 0.016, respectively). Collectively, our findings suggest that, in the Chinese population, the risk of developing PTOM was increased by the association between NLRP3 rs10754558 and rs7525979. Therefore, our findings may provide novel insights and guidance in the prevention and development of PTOM.
... coX-1 is coX-1 is constitutively expressed in the majority of cell types regulating vascular homeostasis. coX-2 enzyme is encoded by the COX-2 gene, located at chromosome 1q25.2-25.3 and consists of 10 exons and nine introns (104). it is an inducible enzyme exhibiting either a low or no expression in the majority of tissues under normal physiological status (105); however, it can function upon proper induction. ...
Article
Full-text available
Previous research has revealed an association between endometriosis and various autoimmune diseases, while recent data suggest, for the first time, an association between endometriosis and the risk of developing ankylosing spondylitis (AS). AS, the prototype of spondyloarthritides diseases, is a systemic, chronic, immune‑mediated inflammatory arthritis, which primarily affects the spine and sacroiliac joints, as well as the axial skeleton with or without extraspinal manifestations. AS is of polygenic inheritance and numerous immunologically relevant genes contribute to its development. Endometriosis is an enigmatic, relatively common, benign, estrogen‑dependent, heterogeneous gynecological disease, influenced by multiple genetic, epigenetic and environmental factors. It is characterized by the growth of endometrial tissue occurring in sites other than the uterine cavity, most commonly in the pelvic cavity, including the ovaries and the uterosacral ligaments, affecting up to 10% of the female population of childbearing age, causing pain and infertility. The present review discusses whether a partially shared genetic background may explain the co‑occurrence of these disorders, as well as potential similarities regarding the underlying pathogenetic mechanisms and specific molecular and cellular pathways.
... Recently, growing evidence has shown that genetic predisposition also plays an important role in FRI development, with single nucleotide variation (SNV) as a representative. Several SNV sites have been found to be associated with the risk of FRI development, such as rs689466 (cyclooxygenase-2, COX-2 gene) [8]; rs16944, rs2234663, rs1143627, rs4251961, and rs1800796 (interleukin, IL genes) [1,9]; and rs2430561 (interferon-γ, IFN-γ gene), demonstrating that as a host factor, SNV is also involved in developing FRI. ...
Article
Full-text available
Variations in the vitamin D receptor (VDR) gene are related to several inflammatory disorders. However, the potential links between such alternations and the risk of developing late fracture-related infection (FRI) remain unclear. This study investigated associations between genetic variations in the VDR and susceptibility to late FRI in the Chinese Han population. Between January 2016 and December 2019, 336 patients with late FRI and 368 healthy controls were genotyped six VDR genetic variations, including ApaI (rs7975232), BsmI (rs1544410), FokI (rs2228570), TaqI (rs731236), GATA (rs4516035), and Cdx-2 (rs11568820). Significant associations were observed between rs7975232 and FRI susceptibility in the recessive ( P = 0.019 , OR = 0.530 , 95% CI 0.310–0.906) model. Patients with AA genotype had a relatively higher level of serological vitamin D (20.6 vs. 20.3 vs. 17.9 ng/ml) ( P = 0.021 ) than those of AC and CC genotypes. Although no statistical differences were observed, potential correlations may exist between rs1544410 (dominant model: P = 0.079 , OR = 0.634 ), rs2228570 (dominant model: P = 0.055 , OR = 0.699 ), and rs4516035 (dominant model: P = 0.065 , OR = 1.768 ) and the risk of FRI development. In the Chinese cohort, ApaI was associated with a decreased risk of developing FRI, and patients with the AA genotype had a higher vitamin D level. Further studies are required to assess the role of genetic variations in BsmI, FokI, and GATA in the pathogenesis of late FRI.
... The association of the rs45567233 polymorphism with the susceptibility of osteomyelitis might be achieved by elevating serum CTSG activity and lactoferrin levels. Wang et al. (2017) have concluded that the G allele and GG genotype of rs689466 located in the PTGS2 gene (COX-2) could be considered a risk factor contributing to the onset of posttraumatic osteomyelitis. Serum C-reactive protein (p = 0.017) and IL-6 (p = 0.006) levels were significantly higher in patients with posttraumatic osteomyelitis accompanied with the GG genotype, instead of the CG genotype. ...
Article
Full-text available
Background: Osteomyelitis is an inflammatory process characterized by progressive bone destruction. Moreover, chronic bacterial osteomyelitis is regarded as a difficult-to-treat clinical entity due to its long-standing course and frequent infection recurrence. However, the role of genetic factors in the occurrence and development of bacterial osteomyelitis is poorly understood. Methods: We performed a systematic review to assess the frequency of individual alleles and genotypes of single-nucleotide polymorphisms (SNPs) among patients with bacterial osteomyelitis and healthy people to identify whether the SNPs are associated with the risk of developing bacterial osteomyelitis. Then, gene ontology and Kyoto Encyclopedia of Gene and Genomes analyses were performed to identify the potential biological effects of these genes on the pathogenesis of bacterial osteomyelitis. Result: Fourteen eligible studies containing 25 genes were analyzed. In this review, we discovered that the SNPs in IL1B, IL6, IL4, IL10, IL12B, IL1A, IFNG, TNF, PTGS2, CTSG, vitamin D receptor (VDR), MMP1, PLAT, and BAX increased the risk of bacterial osteomyelitis, whereas those in IL1RN and TLR2 could protect against osteomyelitis. The bioinformatic analysis indicated that these osteomyelitis-related genes were mainly enriched in inflammatory reaction pathways, suggesting that inflammation plays a vital role in the development of bacterial osteomyelitis. Furthermore, functional notation for 25 SNPs in 17 significant genes was performed using the RegulomeDB and NCBI databases. Four SNPs (rs1143627, rs16944, rs2430561, and rs2070874) had smaller scores from regulome analysis, implying significant biological function. Conclusion: We systematically summarized several SNPs linked to bacterial osteomyelitis and discovered that these gene polymorphisms could be a genetic factor for bacterial osteomyelitis. Moreover, further large-scale cohort studies are needed to enhance our comprehensive understanding of the development of osteomyelitis to provide earlier individualized preventions and interventions for patients with osteomyelitis in clinical practice.
Preprint
Full-text available
Background: Chronic Obstructive Pulmonary Disease (COPD) is a significant global health issue that often coexists with arterial thrombotic diseases. This study aims to investigate the causal relationship between COPD and these diseases, focusing on the role of systemic inflammation and the NF-κB/COX-2 pathway. Methods: The Two-Sample Mendelian Randomization (TSMR) approach was used to analyze the genetic correlation between COPD and the risks of ischemic stroke (IS) and acute myocardial infarction (AMI) using data from several large biobanks. Additionally, in vivo experiments with ApoE knockout mice and in vitro assays with primary mouse aorta endothelial cells were conducted to explore the role of the NF-κB/COX-2 pathway in COPD-related systemic inflammation. Results: The MR analysis revealed a significant association between COPD and increased risks of IS (OR: 1.152) and AMI (OR: 1.001). In vivo findings showed exacerbated pulmonary dysfunction and atherogenesis in mice with both COPD and high-fat diet (HFD), with notable histological changes in lung and aortic tissues. Inflammatory markers and lipid profiles were significantly altered in these models. In vitro studies demonstrated that COPD-induced systemic inflammation impaired endothelial cell function. These changes were mitigated by inhibiting the NF-κB/COX-2 pathway. Conclusions: This study provides strong evidence of a causal link between COPD and an elevated risk of arterial thrombotic diseases, mediated by systemic inflammation and the NF-κB/COX-2 pathway. These findings highlight the importance of addressing arteriosclerosis and thrombosis formation risks in COPD management and suggest that the NF-κB/COX-2 pathway could be a potential therapeutic target for reducing comorbidity in COPD patients.
Preprint
Full-text available
Background Chronic Obstructive Pulmonary Disease (COPD) is a significant global health issue that often coexists with cardiovascular and cerebrovascular diseases. The aim of this study is to investigate the causal relationship between COPD and these diseases, with a focus on the role of systemic inflammation and the NF-κB/COX-2 pathway. Methods The Two-Sample Mendelian Randomization (TSMR) approach was used to analyze the genetic correlation between COPD and the risks of ischemic stroke (IS) and acute myocardial infarction (AMI) using data from several large biobanks. In addition, in vivo experiments with ApoE knockout mice and in vitro assays with primary mouse aorta endothelial cells were conducted to explore the role of the NF-κB/COX-2 pathway in COPD-related systemic inflammation. Results The MR analysis revealed a significant association between COPD and increased risks of IS (OR: 1.152) and AMI (OR: 1.001). In vivo findings showed exacerbated pulmonary dysfunction and atherogenesis in mice with both COPD and high-fat diet (HFD), with notable histological changes in lung and aortic tissues. Inflammatory markers and lipid profiles were significantly altered in these models. In vitro studies demonstrated that COPD-induced systemic inflammation impaired endothelial cell function. These changes were mitigated by inhibiting the NF-κB/COX-2 pathway. Conclusions This study provides strong evidence of a causal link between COPD and an elevated risk of cardiovascular diseases, mediated by systemic inflammation and the NF-κB/COX-2 pathway. These findings highlight the importance of addressing cardiovascular risks in COPD management and suggest that the NF-κB/COX-2 pathway could be a potential therapeutic target for reducing comorbid cardiovascular conditions in COPD patients.
Article
Full-text available
Background Previous studies have indicated that nitric oxide synthase 2 (NOS2) genetic variations are involved in delayed fracture healing and fracture non-union. Whether these genetic variants associate with the development of osteomyelitis (OM) remains unclear. Here, we analyzed the potential relationships between NOS2 genetic variations and the risk of developing post-traumatic OM (PTOM) in a Chinese Han population. Methods Altogether 704 participants, including 336 PTOM patients and 368 healthy controls, were genotyped of rs2297514 and rs2248814 of the NOS2 gene using the SNaPshot genotyping method. Results Outcomes showed that the frequency of allele C of rs2297514 in the patient group was significantly lower than that in the control group (48.7% vs. 54.5%, P = 0.029, OR = 0.792, 95% CI 0.642 – 0.976). In addition, significant associations were found between rs2297514 and susceptibility to PTOM by the recessive model (P = 0.007, OR = 0.633, 95% CI 0.453 – 0.884), and the homozygous model (P = 0.039, OR = 0.648, 95% CI 0.429 – 0.979). Moreover, patients with the CC genotype of rs2297514 had lower inflammatory biomarkers levels than the TT genotype, especially for the C-reactive protein (CRP) level (median: 4.1 mg/L vs. 8.9 mg/L, P = 0.027). However, no significant relationship was noted between rs2248814 and the risk of developing PTOM. Conclusion In this Chinese cohort, rs2297514 is correlated with a decreased risk of PTOM development, with genotype CC as a protective factor.
Article
Genetic variations in the solute carrier family 11 member 1 (SLC11A1) gene have been implicated in developing inflammatory disorders. However, it is still unclear whether such polymorphisms contribute to the pathogenesis of post-traumatic osteomyelitis (PTOM). Therefore, this study investigated the roles of genetic variations of the SLC11A1 gene (rs17235409 and rs3731865) in PTOM development in a Chinese Han cohort. The SNaPshot method was used for genotyping 704 participants (336 patients and 368 controls) for rs17235409 and rs3731865. Outcomes revealed that rs17235409 increased the risk of PTOM occurrence by dominant (P = 0.037, OR = 1.44) and heterozygous models (P = 0.035, OR = 1.45), implying AG genotype as a risk factor for PTOM development. In addition, patients with AG genotype had relatively higher levels of inflammatory biomarkers than those with AA and GG genotypes, especially for the white cell blood count (WBC) and C-reactive protein (CRP). Despite no statistically significant differences achieved, rs3731865 may reduce the PTOM susceptibility, suggested by the results of dominant (P = 0.051, OR = 0.67) and heterozygous models (P = 0.068, OR = 0.69) models. In short, rs17235409 confers an elevated chance of developing PTOM, with AG genotype as a risk factor. Whether rs3731865 involves in the pathogenesis of PTOM requires further investigations.
Article
Background Dysmenorrhea with its debilitating effects is a major reproductive disorder experienced by adolescents and young women. Individual differences in the experience and severity of dysmenorrhea and response to NSAIDs suggest that genetic variation in prostaglandin synthesis may play a role. We therefore examined a possible relationship between cyclooxygenase-2 (COX-2) -1195A>G gene polymorphism (rs689466) and menstrual pain. Methods Adolescents and young women of reproductive age (n = 102) were recruited for the study. The participants were given questionnaires to obtain information on their menstrual cycles and numeric rating scale to rate the pain experienced during their menstrual periods. In addition, genotype analysis was done by PCR-RFLP method and statistical analysis was carried out to assess the interaction between the self-reported presence and severity of dysmenorrhea and genotype. Results Dysmenorrhea was reported by 67 (65.7%) of the participants while 35 (34.3%) reported no pain. Among those who reported pain, 5 (7.5%), 28 (5.8%) and 34 (50.7%) reported mild, moderate and severe pain respectively. The frequencies of G and A alleles were 163 and 41 while the frequencies of GG, GA and AA were 70, 23 and 9 respectively. The population was not in Hardy-Weinberg equilibrium (χ2 = 9.053, df = 1, p = 0.003). Carriers of the A allele were more than thrice as likely to report pain as those with no A allele (OR = 3.07, p = 0.025). Conclusion The presence of an A allele of COX-2 gene -1195 A>G polymorphism may predispose to dysmenorrhea.
Article
Full-text available
Chronic osteomyelitis represents a progressive inflammatory process caused by pathogens, resulting in bone destruction and sequestrum formation. It may present with periods of quiescence of variable duration, whereas its occurrence, type, severity and prognosis is multifactorial. The ‘gold standard’ for the diagnosis of chronic osteomyelitis is the presence of positive bone cultures and histopathologic examination of the bone. Its management remains challenging to the treating physician, with a multidisciplinary approach involving radiologists, microbiologists with expertise in infectious diseases, orthopaedic surgeons and plastic surgeons. Treatment should be tailored to each patient according the severity and duration of symptoms, as well as to the clinical and radiological response to treatment. A combined antimicrobial and surgical treatment should be considered in all cases, including appropriate dead space management and subsequent reconstruction. Relapse can occur, even following an apparently successful treatment, which has a major impact on the quality of life of patients and is a substantial financial burden to any healthcare system. Cite this article EFORT Open Rev 2016;1:128–135. DOI: 10.1302/2058-5241.1.000017.
Article
Full-text available
Osteomyelitis is a progressive bone infection disease caused by destructive immunological inflammatory reactions following new bone formation. Anti-inflammatory cytokines are a series of immunoregulatory molecules that control the pro-inflammatory cytokine response. In this study, we investigated 9 single nucleotide polymorphisms in 5 different cytokine/cytokine receptor genes in hematogenous osteomyelitis (HO) patients, and compared their outcomes with normal healthy individuals. Sequence-specific forward and reverse primers and two TaqMan® MGB probes with dyes (VIC™ and FAM™) that specifically detect Allele 1 and Allele 2 of each SNP were utilized. The genotypes CC (P = 0.009) and CT (P = 0.041) of SNP rs2070874, and alleles A (P = 0.044) and G of SNP rs1800871 were significantly different between the patients and healthy controls. The expression of the CC genotype or C allele at rs2070874 was a risk factor for HO development, with higher frequencies of CT and T being found in the control samples. The expression of the A allele of rs1800871 was also significantly higher in patients than in controls, and was therefore considered a risk factor.
Article
Full-text available
Background: Although extremity chronic osteomyelitis is common in China, updated data were still limited regarding its characterizations. The present study aimed to review clinical features of extremity chronic osteomyelitis in Southern China. Methods: A retrospective analysis was conducted in the patients who had sought medical attention from January 2010 to April 2015 for extremity chronic osteomyelitis in Nanfang Hospital in Southern China. Clinical data were collected and analyzed. Results: A total of 394 patients (307 males and 87 females) were included, giving a gender ratio of 3.53. The median age at first diagnosis was 42 years for all. The most frequent type was traumatic osteomyelitis (262 cases, 66.50%), which was mainly caused by open injury (166 cases, 63.36%) and during a road accident (91 cases, 34.73%). Single site infection accounted for 81.98% (323 cases), with tibia (126 cases), femur (79 cases), calcaneus (37 cases) and toes (37 cases) as the top sites. The positive rate of intraoperative culture was 70.63% (214/303), 78.97% (169/214) of which was monomicrobial infection. Staphylococcus aureus (59 cases) was the most frequent bacteria for monomicrobial infection, followed by Pseudomonas aeruginosa (29 cases) and Escherichia coli (11 cases). The positive ratios of preoperative serum white blood cell (WBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) were 21.63%, 64.92%, 53.27%, 42.25%, 72.82% and 66.67%, respectively. The most frequently used intravenous antibiotic was cephalosporins. The overall cure rate was 77.74%, with a total amputation rate of 16.75%. Conclusions: In this representative Chinese cohort, extremity chronic osteomyelitis was mostly caused by open injury and during a road accident, predominated in males and favored the tibia. Staphylococcus aureus was the most frequent pathogenic organism. Preoperative elevated levels of serum IL-6, TNF-α and ESR may be helpful diagnostic indicators of the disease. Most patients achieved a favorable clinical efficacy after appropriate treatment.
Article
Full-text available
The aim of the present study was to determine the association between polymorphisms in the cyclooxygenase‑2 (COX‑2) gene promoter region, rs20417 G/C and rs2745557 G/A, and the susceptibility to colorectal cancer (CRC) in a Han Chinese population in Shaanxi, China. Polymerase chain reaction and restriction fragment length polymorphism (PCR‑RFLP) were used to detect the polymorphisms of COX‑2, rs20417 G/C and rs2745557 G/A, in 300 patients with CRC and 300 healthy individuals in the present case‑control study. The results revealed that for the COX‑2 rs20417 G/C polymorphism, the GC+CC allele frequency was 80% in CRC patients and 71% in healthy controls [odds ratio (OR)=1.63; 95% confidence interval (CI), 1.12‑2.38; P=0.01]. For the COX‑2 rs2745557 G/A polymorphism, the GA+AA allele frequency was 84% in CRC patients and 73% in healthy controls (OR=1.94; 95% CI, 1.30‑2.90; P<0.01). In addition, among individuals with a smoking history, drinking history or family history of CRC, those who were COX‑2 rs20417 (GC+CC) or COX‑2 rs2745557 (GA+AA) carriers had a significantly increased risk of developing CRC compared with that of GG genotype carriers (P<0.05). Furthermore, the allelic frequencies of COX‑2 rs20417 G/C and rs2745557 G/A in patients with lymph node metastasis in stage Ⅲ/Ⅳ of CRC were significantly different from those of COX‑2 rs20417 G/C and rs2745557 G/A in patients without lymph node metastasis in stage Ⅰ/Ⅱ (P<0.05). In conclusion, the results of the present study revealed that COX‑2 rs20417 C allele carriers and rs2745557 A allele carriers have a significantly increased risk of CRC compared with GG genotype carriers; in addition, the frequencies of these alleles were demonstrated to be associated with lymph node metastasis and CRC progression.
Article
Full-text available
An association between occult infection and the development of rheumatoid arthritis (RA) has been suggested. This study aimed to determine if patients with chronic osteomyelitis (COM) are at increased risk of developing RA. A national insurance claim dataset of 22 million enrollees in Taiwan was used to identify 21,105 hospital inpatients with COM and 84,420 reference subjects matched by sex, age, and index date of diagnosis with a mean of 5.12 years of follow-up from 2000 to 2011. The risk of RA development was analyzed using Cox proportional hazards modeling. The mean age of hospital inpatients with COM was 55.8 ± 19.4 years. The incidence of RA was 5.43 per 10(4) person-years in the case cohort, which was more than twofold higher than that of 2.20 per 10(4) person-years in the reference cohort. After adjustment, the hazard ratio (HR) was 2.21 (95 % confidence interval, 1.51-3.24). The HR was greatest in the youngest age group (<45 years, HR [95 % confidence interval] = 9.08 [3.22-25.6]; 45-64 years, 1.76 [1.01-3.06]; ≥65 years, 1.68 [0.88-3.24]). In addition, HR was greatest in inpatients with more severe COM (HR [95 % confidence interval] = 0.72 [0.40-1.30] and 11.2 [6.63-18.9] for patients with ≤1 or >2 hospitalization due to recurrent osteomyelitis every two follow-up years, respectively). This is the first report linking COM to risk of incident RA. Patients of a younger age and with frequently recurrent COM had a greater increase in RA risk.
Article
Full-text available
Background: The epidemiology of osteomyelitis in the United States is largely unknown. The purpose of this study was to determine long-term secular trends in the incidence of osteomyelitis in a population-based setting. Methods: The study population comprised 760 incident cases of osteomyelitis first diagnosed between January 1, 1969, and December 31, 2009, among residents of Olmsted County, Minnesota. The complete medical records for each potential subject were reviewed to confirm the osteomyelitis diagnosis and to extract details on anatomical sites, infecting organisms, etiological risk factors, and outcomes. Results: The overall age and sex-adjusted annual incidence of osteomyelitis was 21.8 cases per 100,000 person-years. The annual incidence was higher for men than for women and increased with age (p < 0.001). Rates increased with the calendar year (p < 0.001) from 11.4 cases per 100,000 person-years in the period from 1969 to 1979 to 24.4 per 100,000 person-years in the period from 2000 to 2009. The incidence remained relatively stable among children and young adults but almost tripled among individuals older than sixty years; this was partly driven by a significant increase in diabetes-related osteomyelitis from 2.3 cases per 100,000 person-years in the period from 1969 to 1979 to 7.6 cases per 100,000 person-years in the period from 2000 to 2009 (p < 0.001). Forty-four percent of cases involved Staphylococcus aureus infections. Conclusions: The reasons for the increase in osteomyelitis between 1969 and 2009 are unclear but could comprise a variety of factors, including changes in diagnosing patterns or increases in the prevalence of risk factors (e.g., diabetes) in this population.
Article
One of the most challenging complications in trauma surgery is infection after fracture fixation (IAFF). IAFF may result in permanent functional loss or even amputation of the affected limb in patients who may otherwise be expected to achieve complete, uneventful healing. Over the past decades, the problem of implant related bone infections has garnered increasing attention both in the clinical as well as preclinical arenas; however this has primarily been focused upon prosthetic joint infection (PJI), rather than on IAFF. Although IAFF shares many similarities with PJI, there are numerous critical differences in many facets including prevention, diagnosis and treatment. Admittedly, extrapolating data from PJI research to IAFF has been of value to the trauma surgeon, but we should also be aware of the unique challenges posed by IAFF that may not be accounted for in the PJI literature. This review summarizes the clinical approaches towards the diagnosis and treatment of IAFF with an emphasis on the unique aspects of fracture care that distinguish IAFF from PJI. Finally, recent developments in anti-infective technologies that may be particularly suitable or applicable for trauma patients in the future will be briefly discussed.
Article
Background: Many studies have investigated the association between the cyclooxygenase-2 (COX-2) gene polymorphism and ischemic stroke. However, results of these studies still remain controversial. To better explain the association between COX-2 polymorphisms (-765G/C and -1195G/A) and ischemic stroke risk, a meta-analysis was performed. Methods: Relevant studies were identified from 4 Chinese databases (Chinese Biological Medical Literature database, Chinese National Knowledge Infrastructure database, Chongqing VIP database, and Chinese WANFANG database), PUBMED and EMBASE prior to December 2015. The strength of association between COX-2 polymorphism and ischemic stroke was evaluated by the odds ratio (OR) with 95% confidence interval (CI). Inconsistency index (I(2)) and the Cochran's Q statistic were used to check heterogeneity. Publication bias was evaluated by funnel plots and Egger's regression test. Results: A total of 4086 ischemic stroke cases and 4747 controls were identified. Significant association between COX-2 -765G/C polymorphism and the risk of ischemic stroke was found in Brazilians and the African-Americans. The OR of (CC+GC versus GG) for the Brazilians and African-Americans were (6.328, 95% CI = 2.295-17.448) and (1.644, 95% CI = 1.060-2.551). In addition, the recessive model of the Brazilians gave an OR of 3.621 (95% CI: 1.519-8.630). Furthermore, the (GC versus GG) and the allele model of the African-Americans were (OR: 1.615, 95% CI = 1.015-2.572) and (OR: 1.422, 95% CI = 1.033-1.957). Significant association was also observed for COX-2 -1195G/A polymorphism in the subtypes of small vessel disease (SVD) of ischemic stroke. Conclusions: Our study suggests that COX-2 -765G/C and -1195G/A polymorphisms may contribute to susceptibility of ischemic stroke, specifically in Brazilians and the African-Americans, and those of SVD.
Article
Background: With the shift of our healthcare system toward a value-based system of reimbursement, complications such as surgical site infections (SSI) may not be reimbursed. The purpose of our study was to investigate the costs and risk factors of SSI for orthopedic trauma patients. Methods: Through retrospective analysis, 1819 patients with isolated fractures were identified. Of those, 78 patients who developed SSIs were compared to 78 uninfected control patients. Patients were matched by fracture location, type of fracture, duration of surgery, and as close as possible to age, year of surgery, and type of procedure. Costs for treatment during primary hospitalization and initial readmission were determined and potential risk factors were collected from patient charts. A Wilcoxon test was used to compare the overall costs of treatment for case and control patients. Costs were further broken down into professional fees and technical charges for analysis. Risk factors for SSIs were analyzed through a chi-squared analysis. Results: Median cost for treatment for patients with SSIs was $108,782 compared to $57,418 for uninfected patients (p < 0.001). Professional fees and technical charges were found to be significantly higher for infected patients. No significant risk factors for SSIs were determined. Conclusions: Our findings indicate the potential for financial losses in our new healthcare system due to uncompensated care. SSIs nearly double the cost of treatment for orthopedic trauma patients. There is no single driver of these costs. Reducing postoperative stay may be one method for reducing the cost of treating SSIs, whereas quality management programs may decrease risk of infection.